Zhende Reconciled Depreciation from 2010 to 2024
| 603301 Stock | 22.66 0.02 0.09% |
Reconciled Depreciation | First Reported 2010-12-31 | Previous Quarter 243 M | Current Value 132.5 M | Quarterly Volatility 58.6 M |
Check Zhende Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Zhende Medical's main balance sheet or income statement drivers, such as Interest Expense of 18.6 M, Other Operating Expenses of 58.4 M or Net Income Applicable To Common Shares of 584 M, as well as many indicators such as . Zhende financial statements analysis is a perfect complement when working with Zhende Medical Valuation or Volatility modules.
Zhende | Reconciled Depreciation |
Currently Active Assets on Macroaxis
Other Information on Investing in Zhende Stock
Zhende Medical financial ratios help investors to determine whether Zhende Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Zhende with respect to the benefits of owning Zhende Medical security.